The HTG EdgeSeq DLBCL Cell of Origin Assay is a research-use only assay to characterizes diffuse large B-cell lymphoma (DLBCL) into the activated B-cell like (ABC), germinal center B-cell like (GCB) or unclassified subtype using a single 5 µm formalin-fixed, paraffin-embedded (FFPE) tissue section including core needle biopsies. The DLBCL Cell of Origin Assay utilizes our automated HTG EdgeSeq system coupled with the sensitivity and dynamic range of next-generation sequencing (NGS)-based detection, and can be performed in lab using the HTG EdgeSeq system.
Diffuse Large B Cell Lymphoma
AKT1 (V-akt murine thymoma viral oncogene homolog 1), BCL2 (B-cell CLL/lymphoma 2), BCL6 (B-cell CLL/lymphoma 6), CD19 (CD19 Molecule), CD276 (CD276 Molecule), CTLA4 (Cytotoxic T-Lymphocyte Associated Protein 4)
See More ...
Next-Generation Sequencing (NGS)